Tag: COVID19
FiercePharmaPolitics—Latest need-to-know about President Trump’s COVID-19 case
President Donald Trump’s COVID-19 diagnosis and details about his care dominated headlines over the weekend. We’re bringing coverage and analysis to you in a news roundup.
Pharma...
Trump takes Regeneron’s experimental antibodies hours after COVID-19 diagnosis
In a bombshell development Thursday, President Donald J. Trump tested positive for COVID-19, sending shockwaves through the country with just weeks until Election Day....
Decentralized clinical trials won’t slow down after Covid-19 pandemic ends
If you’re reading this article, whether or not you’re attending the online MedCity INVEST Digital Health conference, chances are that you’re doing so at...
Valneva signs manufacturing partner to produce adjuvant for COVID-19 vaccine
French drugmaker Valneva hasn't captured the global attention of some of its larger counterparts in the race for a COVID-19 vaccine, but a recent...
CMS to penalize hospitals, labs that don’t report Covid-19 data
A close-up view of a swab used by medical workers tend to administer the coronavirus test at the drive-in center at ProHealth Care on...
Moderna outlook too rosy amid multiple potential COVID-19 vaccines: analyst
Moderna’s mRNA COVID-19 vaccine candidate was the first U.S. shot to enter late-stage testing, but that doesn’t necessarily mean it has the brightest future...
Moderna to supply up to 160M doses of Covid-19 vaccine to...
EU Flags at the European Commission Building
A deal between one of the companies in the lead to develop a vaccine against the virus that...
FiercePharmaAsia—China’s price-slashing round; Takeda’s Japan cuts; Sinopharm’s COVID-19 vaccine price
Multinational pharmas, including Eli Lilly, Pfizer, Merck & Co. and AstraZeneca, lost to local generic makers in China's third round of bulk procurement bidding...
Roche, Regeneron join forces to more than triple manufacturing of COVID-19...
Despite hundreds of potential therapies for COVID-19 looking to make their case, very few have crossed the finish line. One promising candidate, Regeneron's two-antibody...
Pharma reputation reset with COVID-19 means regaining science and innovation halo:...
Pharma companies have a unique opportunity to reset individual and industry reputations during the COVID-19 crisis. Positive consumer sentiment is way up, and people are rediscovering...
